Loading funding events...
Company Name Funding Type Date Awarded Vertical
PhorMed Equity March 26, 2022 Biopharmaceuticals
BioCurity Pharmaceuticals Equity March 25, 2020 Biopharmaceuticals
Bluejay Therapeutics Series C May 09, 2024 Biopharmaceuticals
BioCurity Pharmaceuticals Inc. Equity January 01, 2024 Biopharmaceuticals
RS BioTherapeutics Convertible Notes April 24, 2024 Biopharmaceuticals
Amlogenyx Inc. Seed August 02, 2024 Biopharmaceuticals
Idrx Series B August 07, 2024 Biopharmaceuticals
Paradigm Therapeutics Series A May 16, 2025 Biopharmaceuticals
NLS Pharma Equity Financing May 17, 2025 Biopharmaceuticals
Idorsia Debt Restructuring May 18, 2025 Biopharmaceuticals
BioVersys AG IPO January 29, 2025 Biopharmaceuticals
Helicore Biopharma Series A January 28, 2025 Biopharmaceuticals
Takeda Grant May 19, 2025 Biopharmaceuticals
Kailera Therapeutics Series A January 04, 2025 Biopharmaceuticals
AsclepiX Therapeutics Inc. Series A June 24, 2020 Biopharmaceuticals
Arrivo BioVentures LLC Venture May 26, 2016 Biopharmaceuticals
3-V Biosciences Series D January 05, 2015 Biopharmaceuticals
AusperBio Series B December 27, 2024 Biopharmaceuticals
Akarna Therapeutics Series B February 16, 2016 Biopharmaceuticals
BlackThorn Therapeutics Series A October 21, 2016 Biopharmaceuticals